Airway Management in Morbidly Obese Patients: A Comparison of Intubating Laryngeal Mask Fastrack and Air Q as a Conduit for Fiberoptic Intubation
1 other identifier
interventional
80
1 country
1
Brief Summary
To compare air Q versus ILMA intubation in obese adult paralyzed patient
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2020
CompletedFirst Submitted
Initial submission to the registry
June 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 1, 2020
CompletedJanuary 4, 2023
January 1, 2023
1 year
June 28, 2020
January 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
success rate of tracheal intubation through each device.
success rate of tracheal intubation through each device is defined as end tidal carbon dioxide confirmed placement of TT within a maximum of 5 min tracheal intubation time
Within a maximum of 5 minutes to confirm success of tracheal intubation through each supraglottic airway devices
Secondary Outcomes (1)
Insertion time of supraglottic airway devices
It is about 13-19 second for insertion of supraglottic airway devices
Study Arms (2)
Group I ( Air Q)
ACTIVE COMPARATORnsertion of proper size Air-Q. ILA
Group II (ILMA)
ACTIVE COMPARATORnsertion of proper size ILMA
Interventions
Success of fiberoptic guided intubation throuhgh Air Q supraglottic airway device
Success of fiberoptic guided intubation throuhgh ILMA supraglottic airway device
Eligibility Criteria
You may qualify if:
- ASA physical status (I-II)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University
Zagazig, 002055, Egypt
Related Publications (2)
Frappier J, Guenoun T, Journois D, Philippe H, Aka E, Cadi P, Silleran-Chassany J, Safran D. Airway management using the intubating laryngeal mask airway for the morbidly obese patient. Anesth Analg. 2003 May;96(5):1510-1515. doi: 10.1213/01.ANE.0000057003.91393.3C.
PMID: 12707159BACKGROUNDKarim YM, Swanson DE. Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach) and the Air-Q. Anaesthesia. 2011 Mar;66(3):185-90. doi: 10.1111/j.1365-2044.2011.06625.x.
PMID: 21320087BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Heba M EL-Asser, MD
Zagazig University
- STUDY CHAIR
Khadiga M El Hossiney, MD
Zagazig University
- STUDY CHAIR
Amani A Aly
Zagazig University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
June 28, 2020
First Posted
July 1, 2020
Study Start
June 20, 2019
Primary Completion
June 20, 2020
Study Completion
June 20, 2020
Last Updated
January 4, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share